Your search returned 8 results.

Results
	1.	The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice. [electronic resource] by Bobardt, Michael Kuo, Joseph Chatterji, Udayan Wiedemann, Norbert Vuagniaux, Gregoire Gallay, Philippe Producer: 20200416 In: PloS one vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer. [electronic resource] by Tao, Zhen McCall, Neal S Wiedemann, Norbert Vuagniaux, Grégoire Yuan, Zhiyong Lu, Bo Producer: 20200413 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate. [electronic resource] by Bobardt, Michael Kuo, Joseph Chatterji, Udayan Chanda, Sumit Little, Susan J Wiedemann, Norbert Vuagniaux, Gregoire Gallay, Philippe A Producer: 20191105 In: PloS one vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death. [electronic resource] by Thibault, Benoît Genre, Ludivine Le Naour, Augustin Broca, Clothilde Mery, Eliane Vuagniaux, Grégoire Delord, Jean Pierre Wiedemann, Norbert Couderc, Bettina Producer: 20191022 In: Scientific reports vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma. [electronic resource] by Matzinger, Oscar Viertl, David Tsoutsou, Pelagia Kadi, Linda Rigotti, Stefania Zanna, Claudio Wiedemann, Norbert Vozenin, Marie-Catherine Vuagniaux, Grégoire Bourhis, Jean Producer: 20160601 In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 116 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells. [electronic resource] by Langdon, Casey G Wiedemann, Norbert Held, Matthew A Mamillapalli, Ramanaiah Iyidogan, Pinar Theodosakis, Nicholas Platt, James T Levy, Frederic Vuagniaux, Gregoire Wang, Shaomeng Bosenberg, Marcus W Stern, David F Producer: 20160907 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. [electronic resource] by Deka, Jürgen Wiedemann, Norbert Anderle, Pascale Murphy-Seiler, Fabienne Bultinck, Jennyfer Eyckerman, Sven Stehle, Jean-Christophe André, Sylvie Vilain, Nathalie Zilian, Olav Robine, Sylvie Delorenzi, Mauro Basler, Konrad Aguet, Michel Producer: 20101110 In: Cancer research vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer. [electronic resource] by Moor, Andreas E Anderle, Pascale Cantù, Claudio Rodriguez, Patrick Wiedemann, Norbert Baruthio, Frédérique Deka, Jürgen André, Sylvie Valenta, Tomas Moor, Matthias B Győrffy, Balázs Barras, David Delorenzi, Mauro Basler, Konrad Aguet, Michel Producer: 20161020 In: EBioMedicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)